Nothing new here in what has been posted, but this time the predictions are coming from within Ernst and Young from India. BD The Indian clinical trials market is predicted to continue its growth despite the current financial climate, according to a partner at Ernst & Young India’s Healthsciences...
Posted to
The Medical Quack .... by Barbara Duck
on 11-25-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, clinical trials, R and D, India, Economics, Outsourcing, Employment, Clinic
Helpful news for the former employees of Amgen, they get an extension on paying off a 2nd mortgage, but some feel this will help, but still not perhaps save the boat. Pharma layoffs in recent years have primarily been in the area of sales and marketing; however now with mergers, acquisitions...